Prophylactic beta-blockers and noncardiac surgery: It's complicated!
September 18, 2013|Hospitalist News (Archived)
Author and Disclosure Information
AT THE ESC CONGRESS 2013
"Patient safety being paramount, guidelines for perioperative beta-blocker initiation should be retracted without further delay," the meta-analysts argued (Heart 2013 July 31 [doi: 10.1136/heartjnl-2013-304262]).
"I read that meta-analysis with great interest," Dr. Andersson said. "I think there definitely is a heterogeneity in the effects of perioperative beta-blockers, and it depends on your baseline risk. Most of the studies in the meta-analysis included many patients at lower risk."
Dr. Andersson’s study was funded by the Danish Medical Research Foundation. She reported having no financial conflicts of interest.
